Reduced expression of the membrane skeleton protein beta1-spectrin (SPTBN1) is associated with worsened prognosis in pancreatic cancer.

MLA

Jiang, Xiaohua, et al. “Reduced Expression of the Membrane Skeleton Protein Beta1-Spectrin (SPTBN1) Is Associated with Worsened Prognosis in Pancreatic Cancer.” Histology and Histopathology, vol. 25, no. 12, Dec. 2010, pp. 1497–506. EBSCOhost, https://doi.org/10.14670/HH-25.1497.

APA

Jiang, X., Gillen, S., Esposito, I., Giese, N. A., Michalski, C. W., Friess, H., & Kleeff, J. (2010). Reduced expression of the membrane skeleton protein beta1-spectrin (SPTBN1) is associated with worsened prognosis in pancreatic cancer. Histology and Histopathology, 25(12), 1497–1506. https://doi.org/10.14670/HH-25.1497

Chicago

Jiang, Xiaohua, Sonja Gillen, Irene Esposito, Nathalia A Giese, Christoph W Michalski, Helmut Friess, and Jörg Kleeff. 2010. “Reduced Expression of the Membrane Skeleton Protein Beta1-Spectrin (SPTBN1) Is Associated with Worsened Prognosis in Pancreatic Cancer.” Histology and Histopathology 25 (12): 1497–1506. doi:10.14670/HH-25.1497.